Upper Limb Exosuit for Clinic Assistance
Smart Rehabilitation Exosuits for Clinic and Home Assistance
Aim is to do a feasibility and refinement trial to assess the safety and comfort of the robotic device and their preliminary effect on muscular activity during the performance of activities of daily living.
The study was carried out with 10 stroke participants who had to carry out a series of 10 functional tasks with and without the suit over 3 sessions.
The results are encouraging and show the potential of using wearable robotic devices in a clinical setting.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Each participant completed 3 ninety-minute long sessions at CART over the course of a week. All participants were closely supervised by 1 occupational therapist and 1 engineer involved in the development of the devices. In the first session, screening of the patient was performed, where the patient's demographics and clinical parameters were collected, including the grip strength of the affected hand measured by a hand dynamometer taking the mean of 2 attempts, and MOCA, FMA and MAS scores. Afterwards, a familiarisation phase was conducted, where the participant trialled the robotic devices to understand their mechanisms and learn how to use them. This phase also allowed the researchers to adjust the fitting of the exoskeletons and tuning the control algorithm of the elbow exoskeleton to the biomechanics of each user, in order to achieve best comfort and assistance.
The participants were instructed to perform a series of elbow/finger flexion and extension movements to understand how to control the exoskeletons. The participants also interacted with different objects (cup, cube, ball) to adjust the positioning of the anchor points in the glove to the position the participants felt most comfortable with. Once the optimised fitting of the devices was identified, the obtained parameters were stored, and the configuration of the devices was left unchanged for reuse in the next session.
In the 2 remaining sessions, participants performed a series of 10 functional tasks. The tasks were performed without assistance (NO-EXO condition) and with assistance (EXO condition) of the exoskeletons. The tasks were performed first in the unpowered condition to allow the participants to familiarise themselves with the tasks before performing them with the assistance of the devices.
The participants were instructed to start every attempt at a task from a position marked on the floor, and with their arms fully relaxed. This was to ensure that variability from unknown factors was minimised. The participants then awaited the instruction from the researchers to commence the task, given in the form of a spoken command triggered by the press of a button. The button was pressed again to signal the end of the task, defined by the following in order of priority: 1) participant decided to stop; 2) the participant dropped the object; 3) therapist decided to stop after deciding the participant was experiencing difficulties and further attempts would not contribute to a successful performance of the task; 4) task is successfully completed.
In addition to the performance of functional tasks, the standing horizontal fingertip reaching distance and the elbow ROM were measured using a measuring tape and a goniometer, respectively.
At the end of the 3rd session, the participants were asked to fill up a questionnaire to provide their subjective feedback regarding comfort, ergonomics, ease of use, overall clinical benefit and user satisfaction.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Singapore, Singapur, 308433
- Tan Tock Seng Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patient with motor deficit(s) due to stroke as diagnosed by CT or MRI, who are attending outpatient rehabilitation services at TTSH Rehabilitation Centre and Centre for Advanced Rehabilitation Therapeutics;
- Patient with first ever clinical stroke (confirmed on brain imaging);
- Post stroke of at least 3 months with stable neurological status;
- Age between 21 to 80 years, inclusive;
- Hemiplegic pattern and shoulder abduction Medical Research Council motor power > 2/5;
- Able to give and sign informed consent at research site;
- Montreal Cognitive Assessment >= 22/30.
Exclusion Criteria:
- Patient with severe cognitive, perceptual (include hemi-neglect), and/or emotional-behavioural issues that preclude participation;
- Experiencing moderate to severe levels of pain (visual numeric pain rating scale > 5);
- Has unstable or terminal medical conditions which may affect participation (e.g. unresolved sepsis, postural hypotension, end stage renal failure) or anticipated life expectancy of < 1 year due to malignancy or neurodegenerative disorder;
- Non-stroke related causes of arm motor impairment;
- Local factors which may be worsened by arm therapy or device interface: spasticity of MAS > 3, unhealed skin wounds/rashes, shoulder pain visual analog scale > 5/10, active fractures or arthritis or fixed flexion contractures of shoulder, elbow, wrist or fingers incompatible with device interface;
- Inability to tolerate 90 minutes of therapy session;
- Pregnancy or breast feeding;
- Detectable sensory impairment of affected limb---hemianesthesia to sharp pain.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Viabilidad del dispositivo
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Otro: Refinement and Feasibility Trial
It is intra - individual comparison study Arm 1: participant wore the custom-made upper limb exosuit and hand exoskeleton to perform the series of tasks Arm 0: participant perform the same tasks without the custom-made upper limb exosuit and hand exoskeleton. |
Participants go through 3 90-min sessions in a clinic setting and perform a series of functional tasks adapted from motor activity log and bilateral upper limb tasks with and without the device.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Assessment of the elbow module by self-reported evaluation via questionnaire
Periodo de tiempo: End of the 3rd session, median duration of 5 days from baseline
|
Patient self-reported outcome of the ease of use, ranked from 1 to 5, 5 being the easiest and 1 being the least easy.
|
End of the 3rd session, median duration of 5 days from baseline
|
|
Assessment of the hand module by self-reported evaluation via questionnaire
Periodo de tiempo: End of the 3rd session, median duration of 5 days from baseline
|
Patient self-reported outcome of the ease of use, ranked from 1 to 5, 5 being the easiest and 1 being the least easy.
|
End of the 3rd session, median duration of 5 days from baseline
|
|
Successful completion of tasks (without intervention)
Periodo de tiempo: At 2nd session, median time of 2 days from baseline
|
The success of the tasks without the assistance of the exoskeletons was evaluated by the clinician.
|
At 2nd session, median time of 2 days from baseline
|
|
Successful completion of tasks (with intervention)
Periodo de tiempo: At 3rd session, median time of 5 days from baseline
|
The success of the tasks with the assistance of the exoskeletons was evaluated by the clinician.
|
At 3rd session, median time of 5 days from baseline
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Upper limb angular trajectory (without intervention)
Periodo de tiempo: Average over the 2nd session, median time of 2 days from baseline
|
The upper limb angular trajectories while not wearing the exoskeletons were measured via Inertial Measurement Units (IMUs) to investigate changes in movements of the elbow and shoulder joints.
|
Average over the 2nd session, median time of 2 days from baseline
|
|
Upper limb angular trajectory (with intervention)
Periodo de tiempo: Average over the 3rd session, median time of 5 days from baseline
|
The upper limb angular trajectories while wearing the exoskeletons were measured via Inertial Measurement Units (IMUs) to investigate changes in movements of the elbow and shoulder joints.
|
Average over the 3rd session, median time of 5 days from baseline
|
|
Muscular synergies (without intervention)
Periodo de tiempo: Average over the 2nd session, median time of 2 days from baseline
|
The muscular synergies of the users while not wearing the exoskeletons were measured by calculating Pearson's correlation coefficient between muscles.
|
Average over the 2nd session, median time of 2 days from baseline
|
|
Muscular synergies (with intervention)
Periodo de tiempo: Average over the 3rd session, median time of 5 days from baseline
|
The muscular synergies of the users while wearing the exoskeletons were measured by calculating Pearson's correlation coefficient between muscles.
|
Average over the 3rd session, median time of 5 days from baseline
|
|
Muscular effort (without intervention)
Periodo de tiempo: Average over the 2nd session, median time of 2 days from baseline
|
The muscular efforts of the users while not wearing the exoskeletons were measured by surface electromyographic sensors (sEMG), and normalised against the maximum voluntary contraction (MVC) value obtained at the beginning of the session.
|
Average over the 2nd session, median time of 2 days from baseline
|
|
Muscular effort (with intervention)
Periodo de tiempo: Average over the 3rd session, median time of 5 days from baseline
|
The muscular efforts of the users while wearing the exoskeletons were measured by surface electromyographic sensors (sEMG), and normalised against the maximum voluntary contraction (MVC) value obtained at the beginning of the session.
|
Average over the 3rd session, median time of 5 days from baseline
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2018/01358
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .